tranexamic acid has been researched along with Ehlers-Danlos Syndrome in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasui, H | 1 |
| Adachi, Y | 1 |
| Minami, T | 1 |
| Ishida, T | 1 |
| Kato, Y | 1 |
| Imai, K | 1 |
1 other study available for tranexamic acid and Ehlers-Danlos Syndrome
| Article | Year |
|---|---|
Combination therapy of DDAVP and conjugated estrogens for a recurrent large subcutaneous hematoma in Ehlers-Danlos syndrome.
Topics: Adrenochrome; Adult; Blood Transfusion; Combined Modality Therapy; Deamino Arginine Vasopressin; Dru | 2003 |